ALS Limited (CPBLF) reported FY25 revenue growth of 16% to CHF 3.0B, with underlying EBIT up 4.7% and strong cash conversion at 95%. Despite margin compression from acquisitions and pricing pressure ...
Good day, and thank you for standing by. Welcome to ALS Limited H1 FY '26 results briefing. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to ...
ALS Ltd. (CPBLF – Research Report) received a Sell rating and an A$11.35 price target from Jarden analyst Jakob Cakarnis on May 29. The company’s shares closed last Wednesday at $8.15. According to ...
Hosted on MSN
Up 40% this year, Macquarie says this ASX 200 stock can still return double digits from here
Global testing giant ALS Ltd (ASX: ALQ) delivered a solid set of first-half results this week, and brokers, including Macquarie, have a positive outlook on the company's shares, which give exposure to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results